GENERAL18 Sept 2026
Nestle India share price falls 3%: FSSAI takes legal action over 3 baby products
Nestle India shares fell about 3% on September 18 after FSSAI, the food safety regulator, filed three adjudication cases covering Infant Nutrition, NAN Excella and Lactogen. One follow-up formula sample failed Biotin requirements, and promotional claims on e-commerce listings broke infant food rules. If you sell or market infant nutrition products, review your labels and online claims now, and keep lab test reports ready.
Key Statutory Highlights
- FSSAI filed three adjudication cases against Nestle India over Infant Nutrition, NAN Excella and Lactogen.
- A follow-up formula sample failed the prescribed Biotin requirement, and a repeat analysis also found it non-conforming.
- FSSAI said the claims on both products went against the FSS (Foods for Infant Nutrition) Regulations, 2020 and the IMS Act, 1992.
Actionable Advice for Taxpayers / Founders:If you sell or promote infant nutrition products, check your packaging and e-commerce listings against FSSAI's claims rules, and speak to a food law advisor before publishing any health or nutrition claim.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: